Efficacy of extended thrombo-prophylaxis in major abdominal surgery: What does the evidence show? A meta-analysis

Thrombosis and Haemostasis

Volumn 99, Issue 6, 2008, Pages 1104-1111

  Bottaro, Federico Jorge ^a   Elizondo, Maria Cristina ^a   Doti, Carlos ^a   Bruetman, Julio Enrique ^a   Moreno, Pablo Diego Perez ^a   Bullorsky, Eduardo Oscar ^a   Ceresetto, Jose Manuel ^a  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Cancer; Extended thrombo prophylaxis; Low molecular weight heparins; Major abdominal surgery; Venous thromboembolism

Indexed keywords

ANTIVITAMIN K; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ABDOMINAL SURGERY; ARTICLE; BLEEDING; CLINICAL TRIAL; COLON HEMORRHAGE; CONFIDENCE INTERVAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; DUODENAL ULCER BLEEDING; HUMAN; LUNG EMBOLISM; META ANALYSIS; NEOPLASM; PEPTIC ULCER BLEEDING; POSTOPERATIVE CARE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT DURATION; TREATMENT INDICATION; URETHRAL BLEEDING; VENOUS THROMBOEMBOLISM;

ABDOMEN; AGED; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LAPAROTOMY; PUBLICATION BIAS; PULMONARY EMBOLISM; RISK ASSESSMENT; TIME FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 44949261919     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-12-0759     Document Type: Article

References (33)

1. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126(3 Suppl): 338S-400S.
2. Iversen LH, Thorlasius-Ussing O. Relations of coagulation test abnormalities to tumor burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 2002; 87: 402-408.
3. Kakkar A, Haas S, Walsh D, et al. Prevention of peri-operative venous thromboembolism: outcome after cancer and non-cancer surgery. Thromb Haemost 2001; XVIII Congress of ISTH Paris, A OC1732.
4. Seddighzadeh A, Shetty R, Goldhaber S. Venous thromboembolism in patients with active cancer. Thromb Haemost 2007; 98: 656-661.
5. Galster H, Kolb G, Kohsytorz A, et al. The pre-, peri-, and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thromb Res 2000; 100: 381-388.
6. Rasmussen M. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 2002; 28: 141-144.
7. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995; 82: 496-501.
8. Scurr JH, Colerigde-Smith PD, Hasty JH. Deep venous thrombosis: a continuing problem. Br Med J 1988; 297: 28.
9. Sørensen C, Andersen M, Kristiansen VB, et al. The occurrence of late thromboembolic complications after elective abdominal surgery. Ugskr laeg 1990; 152: 1586-1587.
10. Clarke-Pearson DL, Synan IS, Hinshaw WM, et al. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 1984; 63: 92-98.
11. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006; 243: 89-95.
12. Kakkar A, Haas S, Wolf H, et al. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients. Thromb Haemost 2005; 94: 867-871.
13. Mantel H, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
14. Bergqvist D, Solhaug JH, Holmdahl L, et al. Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran: a multicenter study of thromboprophylaxis in elective abdominal surgery. Clin Drug Invest 2004; 24: 124-136.
15. Rasmussen MS, Wille-Jørgensen P. Prolonged out-of-hospital low molecular weight heparin prophylaxis against deep venous thrombosis in patients undergoing major abdominal surgery: a systematic review. Blood 2003; 102: A 1168.
16. Rasmussen MS, Wille-Jørgensen P. Extended out-of-hospital low molecular weight heparin prophylaxis against venous thromboembolism in patients after cancer operations: a meta-analysis. J Thromb Haemost 2001; 3(suppl. 1): P2213.
17. Rasmussen MS. Does prolonged thromboprophylaxis improve outcome in patients undergoing surgery? Cancer Treat Rev 2003; 29(suppl. 2): 15-17.
18. Rasmussen MS, Wille-Jørgensen P, Jorgensen L, et al. Prolonged thromboprophylaxis with low molecular weight heparin (Dalteparin) following major abdominal surgery for malignancy. Blood 2003; 102: A186.
19. Rasmussen MS, Wille-Jørgensen P, Jorgensen L, et al. Prolonged thromboprophylaxis with Dalteparin may improve survival in patients operated on for abdominal cancer. J Thromb Haemost 2005; 3 (Suppl 1): P2187.
20. Jorgensen LN, Lausen I, Rasmussen MS, et al. Prolonged thromboprophylaxis with low molecular weight heparin (tinzaparin) following major general surgery primarily for cancer: an individual patient data meta-analysis. J Thromb Haemost 2003; 1 (Suppl 1): P1870.
21. Rasmussen MS, Wille-Jørgensen P, Jorgensen L, et al. Prolonged thromboprophylaxis with low molecular weight heparin (Dalteparin) following major abdominal surgery prevents late VTE: the FAME study. Pathophysiol Haemost Thromb 2003; 33 (Suppl 1): 77-104.
22. Rasmussen MS, Wille-Jørgensen P, Jorgensen L, et al; on behalf of the FAME investigators. Prolonged prophylaxis with dalteparin to prevent late thromboem bolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost 2006; 4: 2384-2390.
23. Bergqvist D, Agnelli G, Cohen AT, et al; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346: 975-980.
24. Lausen I, Jensen R, Jorgensen LN, et al. Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis. Eur J Surg 1998; 164: 657-663.
25. Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004; 128: 138-146.
26. Mason DP, Quader MA, Blackstone EH, et al. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg 2006; 131: 711-718.
27. Ziomek S, Read RC, Tobler HG, et al. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg 1993; 56: 223-226.
28. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
29. Haas S, Wolf H, Kakkar AK, et al. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin. Thromb Haemost 2005; 94: 814-819.
30. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358: 9-15.
31. Ricotta S, Iorio A, Parise P, et al. Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography - an overview analysis. Thromb Haemost 1996; 76: 887-892.
32. CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation, NCT00219973). Available at: http://clinicaltrials.gov/ct/show/NCT00219973?order=4. Accesed December 15, 2007.
33. Fondaparinux in preventing blood clots in patients undergoing surgery for gynecologic cancer (NCT00381888). Available at: http://www.clinical trials.gov/ct/show/NCT00381888?order=2. Accesed December 15, 2007.